Journal
JOURNAL OF THORACIC ONCOLOGY
Volume 17, Issue 2, Pages 200-213Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2021.10.010
Keywords
Thymoma; Thymic carcinoma; Thymic neuroendocrine tumor; NET G3; Germ cell tumor; WHO classification
Categories
Ask authors/readers for more resources
This article provides an overview of the new developments in the fifth edition of the WHO classification of thymic epithelial tumors, mediastinal germ cell tumors, and mesenchymal neoplasms, focusing on diagnostic, molecular, and conceptual advances. Diagnostic advances include immunohistochemical characterization and the identification of genetic translocations. Molecular and tumor biological advancements include the finding that thymomas and most thymic carcinomas lack currently targetable mutations, but typically have a PD-L1(high) phenotype. Additionally, conceptual advancements for the classification of thymic NETs are discussed.
This overview of the fifth edition of the WHO classification of thymic epithelial tumors (including thymomas, thymic carcinomas, and thymic neuroendocrine tumors [NETs]), mediastinal germ cell tumors, and mesenchymal neoplasms aims to (1) list established and new tumor entities and subtypes and (2) focus on diagnostic, molecular, and conceptual advances since publication of the fourth edition in 2015. Diagnostic advances are best exemplified by the immunohistochemical characterization of adenocarcinomas and the recognition of genetic translocations in metaplastic thymomas, rare B2 and B3 thymomas, and hyalinizing clear cell carcinomas. Advancements at the molecular and tumor biological levels of utmost oncological relevance are the findings that thymomas and most thymic carcinomas lack currently targetable mutations, have an extraordinarily low tumor mutational burden, but typically have a programmed death-ligand 1(high) phenotype. Finally, data underpinning a conceptual advance are illustrated for the future classification of thymic NETs that may fit into the classification scheme of extrathoracic NETs. Endowed with updated clinical information and state-of-the-art positron emission tomography and computed tomography images, the fifth edition of the WHO classification of thymic epithelial tumors, germ cell tumors, and mesenchymal neoplasms with its wealth of new diagnostic and molecular insights will be a valuable source for pathologists, radiologists, surgeons, and oncologists alike. Therapeutic perspectives and research challenges will be addressed as well. (C) 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available